FDAnews Drug Daily Bulletin

QRxPharma, FDA Establish Path Forward for Resubmission of Moxduo NDA

Jan. 17, 2013
A A
QRxPharma Limited announced the steps necessary for approval of immediate release Moxduo (morphine and oxycodone) have been clarified with the FDA.
Daily Markets